151 related articles for article (PubMed ID: 37930454)
1.
Kahts M; Guo H; Kommidi H; Yang Y; Sayman HB; Summers B; Ting R; Zeevaart JR; Sathekge M; Aras O
EJNMMI Radiopharm Chem; 2023 Nov; 8(1):36. PubMed ID: 37930454
[TBL] [Abstract][Full Text] [Related]
2. A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.
Fairclough M; Prenant C; Ellis B; Boutin H; McMahon A; Brown G; Locatelli P; Jones AK
J Labelled Comp Radiopharm; 2016 Jun; 59(7):270-6. PubMed ID: 27061114
[TBL] [Abstract][Full Text] [Related]
3. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies.
Bansal A; Pandey MK; Demirhan YE; Nesbitt JJ; Crespo-Diaz RJ; Terzic A; Behfar A; DeGrado TR
EJNMMI Res; 2015; 5():19. PubMed ID: 25918673
[TBL] [Abstract][Full Text] [Related]
4. A kit formulation for the preparation of [
Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
[TBL] [Abstract][Full Text] [Related]
5. [(89)Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography.
Charoenphun P; Meszaros LK; Chuamsaamarkkee K; Sharif-Paghaleh E; Ballinger JR; Ferris TJ; Went MJ; Mullen GE; Blower PJ
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):278-87. PubMed ID: 25359636
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vivo biodistribution of cells labelled with [
Friberger I; Nilsson JN; Lu L; Siikanen J; Ardenfors O; Milton S; Samén E; Goos JACM; Carlsten M; Holmin S; Tran TA
EJNMMI Res; 2023 Aug; 13(1):73. PubMed ID: 37552341
[TBL] [Abstract][Full Text] [Related]
7. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
[TBL] [Abstract][Full Text] [Related]
8. Automated radiosynthesis of [
Wichmann CW; Poniger S; Guo N; Roselt P; Rudd SE; Donnelly PS; Blyth B; Van Zuylekom J; Rigopoulos A; Burvenich IJG; Morandeau L; Mohamed S; Nowak AK; Hegi-Johnson F; MacManus M; Scott AM
Nucl Med Biol; 2023; 120-121():108351. PubMed ID: 37224789
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Characterization of
Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126
[No Abstract] [Full Text] [Related]
10. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
11. Total-Body PET and Highly Stable Chelators Together Enable Meaningful
Berg E; Gill H; Marik J; Ogasawara A; Williams S; van Dongen G; Vugts D; Cherry SR; Tarantal AF
J Nucl Med; 2020 Mar; 61(3):453-460. PubMed ID: 31562219
[TBL] [Abstract][Full Text] [Related]
12. Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with
Patrick PS; Kolluri KK; Zaw Thin M; Edwards A; Sage EK; Sanderson T; Weil BD; Dickson JC; Lythgoe MF; Lowdell M; Janes SM; Kalber TL
Stem Cell Res Ther; 2020 Jun; 11(1):256. PubMed ID: 32586403
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of the Synthesis and Cell Labelling Conditions for [
Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samén E; Carlsten M; Holmin S; Tran TA
Mol Imaging Biol; 2021 Dec; 23(6):952-962. PubMed ID: 34231103
[TBL] [Abstract][Full Text] [Related]
14. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
[TBL] [Abstract][Full Text] [Related]
15. Radiolabelling and preclinical characterization of
Burvenich IJG; Goh YW; Guo N; Gan HK; Rigopoulos A; Cao D; Liu Z; Ackermann U; Wichmann CW; McDonald AF; Huynh N; O'Keefe GJ; Gong SJ; Scott FE; Li L; Geng W; Zutshi A; Lan Y; Scott AM
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3075-3088. PubMed ID: 33608805
[TBL] [Abstract][Full Text] [Related]
16.
Privé BM; Derks YHW; Rosar F; Franssen GM; Peters SMB; Khreish F; Bartholomä M; Maus S; Gotthardt M; Laverman P; Konijnenberg MW; Ezziddin S; Nagarajah J; Heskamp S
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2064-2076. PubMed ID: 34932154
[TBL] [Abstract][Full Text] [Related]
17.
Zheng KH; Kroon J; Schoormans J; Gurney-Champion O; Meijer SL; Gisbertz SS; Hulshof MCCM; Vugts DJ; van Dongen GAMS; Coolen BF; Verberne HJ; Nederveen AJ; Stroes ESG; van Laarhoven HWM
J Nucl Med; 2022 Dec; 63(12):1880-1886. PubMed ID: 35738904
[TBL] [Abstract][Full Text] [Related]
18. Development of a method for the preparation of zirconium-89 radiolabelled chitosan nanoparticles as an application for leukocyte trafficking with positron emission tomography.
Fairclough M; Ellis B; Boutin H; Jones AKP; McMahon A; Alzabin S; Gennari A; Prenant C
Appl Radiat Isot; 2017 Dec; 130():7-12. PubMed ID: 28923298
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.
Novy Z; Janousek J; Barta P; Petrik M; Hajduch M; Trejtnar F
J Labelled Comp Radiopharm; 2021 Jun; 64(7):262-270. PubMed ID: 33818828
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
